USPTO Rejects Claims of Two Illumina Patents in Non-Final Action After Life Tech Reexam Request

Because of the US Patent and Trademark Office's current review of four Illumina patents, Life Tech has requested to suspend all proceedings in ongoing litigation involving the IP.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.